Inventor · disambiguated record
Jason Duarte Jacintho
Also filed as: JACINTHO JASON · JACINTHO JASON DUARTE
13 granted patents·3 pending applications·11 citations·filing 2013–2024
86Inventor score
Top patents by PatentIndex Score
16 records- 0182US10160742B2Pyridyl reverse sulfonamides for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2017·Granted Dec 25, 2018·1 cites·8 claims
- 0279US2024041837A1Triazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0378US12467928B2N-terminal modifier agents and binders for treating and analyzing peptidesENCODIA INC·Filed 2024·Granted Nov 11, 2025·0 cites·28 claims
- 0477US9597332B2Sulfide alkyl compounds for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2015·Granted Mar 21, 2017·1 cites·9 claims
- 0576US10196351B2Sulfide alkyl compounds for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2017·Granted Feb 5, 2019·1 cites·19 claims
- 0674US10568871B2Triazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2017·Granted Feb 25, 2020·1 cites·20 claims
- 0774US9676754B2Triazolone compounds and uses thereofINCEPTION 2 INC·Filed 2013·Granted Jun 13, 2017·2 cites·18 claims
- 0873US9765050B2Pyridyl reverse sulfonamides for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2015·Granted Sep 19, 2017·1 cites·9 claims
- 0971US9776976B2Triazolone compounds and uses thereofINCEPTION 2 INC·Filed 2014·Granted Oct 3, 2017·2 cites·23 claims
- 1070US10710959B2Sulfide alkyl compounds for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·0 cites·8 claims
- 1169US11666557B2Triazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2019·Granted Jun 6, 2023·0 cites·19 claims
- 1269US9505728B2Triazolone compounds and uses thereofINCEPTION 2 INC·Filed 2013·Granted Nov 29, 2016·2 cites·25 claims
- 1366US10428041B2Pyridyl reverse sulfonamides for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2018·Granted Oct 1, 2019·0 cites·20 claims
- 1448US2022283175A1Metalloenzymes for biomolecular recognition of n-terminal modified peptidesENCODIA INC·Filed 2022·Application pending·0 cites
- 1547US2018079745A1Pyrazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1640US9862708B2Pyrazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →